Fennelly Associates announces it has negotiated a 3,700-square-foot lease with Thrive Financial Services, a 1,945-square-foot lease with Empro Insurance and a 1,450-square-foot lease with Caplin Point Labs at 3840 Quakerbridge Road located in the Van Nest Office Park in Hamilton, N.J. Jerry Fennelly, SIOR, President of Fennelly Associates represented the landlord in all three transactions.
3840 Quakerbridge Road is a 33,000-square-foot, two-story office building located less than two miles from the intersection of Route 1 and Interstate 295. 3840 Quakerbridge Road, joined by an identical adjacent building at 3836 Quakerbridge Road forms the Van Nest Office Park, a modern office campus bordering the Van Nest Wildlife Refuge, a 98-acre wildlife management area. The Van Nest Office Park is just minutes from the Hamilton Train Station with direct access to New York City via the Northeast Corridor Line and is less than 15 minutes from Robert Wood Johnson University Hospital Hamilton.
“Although these businesses operate in different industries and serve different clients, their need for a well-located, modern office is uniform,” said Fennelly. “Despite the difficulties in the broader office market, the strong demand from businesses aiming to tap into Mercer County’s favorable demographics underpins what continues to be a standout local office market.”
Thrive Financial Services is a leading retirement income planning and investment specialty firm with six financial planners, a staff of 29 and four offices across New Jersey and Pennsylvania. The firm specializes in retirement income planning, investment and risk management, forward tax planning, and legacy planning.
Founded in 2020, EmPRO Insurance Company is a wholly owned subsidiary of Physicians’ Reciprocal Insurers, a New York reciprocal insurance exchange. EmPRO’s medical professional liability solutions protect the healthcare communities of New York, New Jersey, Pennsylvania, and Connecticut through a variety of services including risk, malpractice, and peer support; supported by outstanding customer service and aggressive claims defense.
Headquartered in India, Caplin Point Laboratories Limited is engaged in the R&D and manufacture of finished formulations, APIs, front-end generic presence and clinical research for customers across India, Latin America and Africa. Caplin Point has over 4000 product registrations with more than 650 pharmaceutical formulations and over 36 therapeutic sections across the globe.
